Nephros, Inc. Stock Analysis & AI Score
Nephros, Inc. (NEPH) has an ST Score of 60.5 (B), driven by its Growth (A+) and held back by its Valuation (C-). Analysts rate it Buy with a $4.00 price target (-3.4% downside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Instruments & Supplies |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Nephros, Inc. (NEPH) has an ST Score of 60.5 (B), driven by its Growth (A+) and held back by its Valuation (C-). Analysts rate it Buy with a $4.00 price target (-3.4% downside).
- Strongest
- GrowthA+
- Weakest
- ValuationC-
All factor grades
- GrowthA+
- Financial StrengthA
- ProfitabilityA-
- ForecastC+
- MomentumC
- ValuationC-
- Piotroski4/9
Contact
NEPH stock: frequently asked questions
What is NEPH's ST Score?
Nephros, Inc. (NEPH) has an ST Score of 60.5 (B), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is NEPH a buy, hold, or sell?
Analysts rate NEPH a Buy, with a price target of $4.00 (-3.4% vs the current price). Our ST Score grades it B (60.5/100). The ST Score is a data-driven signal, not a recommendation.
What are NEPH's factor grades?
Valuation C-, Profitability A-, Financial Strength A, Momentum C, Growth A+, Forecast C+.
What is NEPH's valuation grade?
Nephros, Inc. (NEPH) earns a valuation grade of C-, measured against Medical - Instruments & Supplies peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is NEPH's growth grade?
Nephros, Inc. (NEPH) earns a growth grade of A+, measured against Medical - Instruments & Supplies peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is NEPH's profitability grade?
Nephros, Inc. (NEPH) earns a profitability grade of A-, measured against Medical - Instruments & Supplies peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is NEPH's financial strength grade?
Nephros, Inc. (NEPH) earns a financial strength grade of A, measured against Medical - Instruments & Supplies peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for NEPH?
The average analyst price target for Nephros, Inc. (NEPH) is $4.00 from 4 analysts, which is -3.4% versus the recent price of $4.14.
What is NEPH's Piotroski score?
Nephros, Inc. (NEPH) has a Piotroski F-Score of 4 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.